BLCM - Bellicum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,120185388282
Cost of Revenue71,58866,52751,84336,745
Gross Profit-70,468-66,342-51,455-36,463
Operating Expenses
Research Development----
Selling General and Administrative24,99821,04516,92512,672
Non Recurring----
Others----
Total Operating Expenses96,58687,57268,76849,417
Operating Income or Loss-95,466-87,387-68,380-49,135
Income from Continuing Operations
Total Other Income/Expenses Net-2,570-4,392-861587
Earnings Before Interest and Taxes-95,466-87,387-68,380-49,135
Interest Expense-4,199-3,672-1,760-12
Income Before Tax-98,036-91,779-69,241-48,548
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-98,036-91,779-69,241-48,548
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-98,036-91,779-69,241-48,548
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-98,036-91,779-69,241-48,548